LexaGene Holdings Inc. (CVE:LXG – Get Free Report) was down 19.2% during mid-day trading on Friday . The stock traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares changed hands during trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Trading Down 19.2 %
The company has a quick ratio of 1.13, a current ratio of 1.39 and a debt-to-equity ratio of 138.01. The firm has a market capitalization of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26. The stock’s fifty day simple moving average is C$0.11 and its 200 day simple moving average is C$0.11.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Stories
- Five stocks we like better than LexaGene
- 3 Healthcare Dividend Stocks to Buy
- MarketBeat Week in Review – 8/28 – 9/1
- High Flyers: 3 Natural Gas Stocks for March 2022
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- What is the FTSE 100 index?
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
